BRD4 and familial pancreatic carcinoma: NR5A2 overexpression induced by BRD4 enhanced the transcription of GDF15 in pancreatic cancer, suggesting that BRD4/NR5A2/GDF15 axis is a potential therapeutic target in pancreatic cancer.